This has contributed to the fact that self-medication is one of the most dynamic drug markets for pharmaceutical companies. Most experts of the domain consider that this practice will accentuate in the coming years. Industrialized countries like France are pushing in this direction by transitioning molecule sets from originally prescribed to OTC,